Wells Fargo & Company »

Briacell Therapeutics Corp shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $7 1 7.00
2025-09-30 $11 1 11.00

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom Put Option (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Call Option (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)

View all positions for Wells Fargo & Company

Top funds holding Briacell Therapeutics Corp

Citadel Advisors
Flagship Harbor Advisors
Federation des caisses Desjardins du Quebec
UBS Group
Royal Bank of Canada
Hanson McClain Advisors
Group One Trading
Ssa Swiss Advisors
TD Waterhouse Canada
FNY Investment Advisers
Tower Research Capital
HHM Wealth Advisors
Wells Fargo & Company

View all funds holding Briacell Therapeutics Corp